Skip to main content
SpringerLink
Log in

Renal transplantation in infants and children

  • Symposium: Pediatric Nephrology
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Renal transplantation is the treatment of choice in children with end stage renal disease. Advances in organ retrieval and preservation, improved surgical techniques and postsurgical care, newer immunosuppressive drugs and prevention and treatment of infections have significantly improved survival of the renal allograft. The absolute requirements for a transplant are compatible blood group and a negative cytotoxic crossmatch. HLA identical grafts have a longer half-life than those that are less well matched. The immunosuppressive drugs most often used are cyclosporin A (or tacrolimus), azathioprine (or mycophenolate mofetil) and prednisone. Complications following transplantation include episodes of acute rejection, serious bacterial and viral infections, hypertension and recurrence of primary disease in the allograft. Each centre must have standard protocols for pre-transplant evaluation, and monitoring during surgery and in the post-operative period. Socio-economic factors should be evaluated before offering renal transplantation to children in developing countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ellis D, Gilboa N, Bellinger M, Shapiro R. Renal transplantation in infants and children. In: Shapiro R, Simmons RL, Starzl TE (eds)Renal Transplantation. Appleton and Lange, Stamford, CT 1997, pp 427–469.

    Google Scholar 

  2. Halloran PF. Immunosuppressive agents in clinical trials in transplantation.Am J Med Sci 1997; 313: 283–288.

    Article  PubMed  CAS  Google Scholar 

  3. Pattison J, and Krensky A. New insights into mechanisms of allograft rejection.Am J Med Sci. 1997; 313: 257–263.

    Article  PubMed  CAS  Google Scholar 

  4. Danovitch GM. Immunosuppressive medications and protocols for kidney transplantation. In: GM Danovitch (ed.)Handbook of Kidney Transplantation, Little Brown and Co., Boston, 1996; pp 55–94.

    Google Scholar 

  5. Suthanthiran M, Strom TB. Renal Transplants. Immunosuppressive drugs: Mechanistic basis for use in organ transplantation.Pediatr Nephrol 1997; 5: 651–657.

    Article  Google Scholar 

  6. Strom TB. Immunosuppression in tissue and organ transplantation In: Brent and Robert Sells (eds.)Organ Transplantation: Current Clinical and Immunologic Concepts. Lislie Balliere Tindall Inc. London, 1989; pp. 39–59.

    Google Scholar 

  7. Kasiske BL, Ramos EL, Gaston RS. The Evaluation of Renal Transplant Candidates; Clinical Practice Guidelines 1995.J Am Soc Nephrol 1995; 6: 1–34.

    Article  PubMed  CAS  Google Scholar 

  8. Scornik JC, Brunson ME, Howard RJ, Pfaff WW. Alloimunization, memory and the interpretation of crossmatch results for renal transplantation.Transplantation 1992; 54: 389–394.

    Article  PubMed  CAS  Google Scholar 

  9. Shapiro R. The transplant procedure. In: Shapiro R, Simmons RL, Starzl TE (eds).Renal Transplantation. Appleton and Lange, Stamford, CT 1997; pp 103–141.

    Google Scholar 

  10. Harmon WE, Sullivan EK. Cyclosporine dosing and its relation to outcome in pediatric renal transplantation.Kid Int. 1993; 44: S50–55.

    Article  Google Scholar 

  11. Shapiro R, Scantlebury VP, Jordan ML. Tacrolimus in Pediatric Renal Transplantation.Transplantation 1996; 62: 1752–1758.

    Article  PubMed  CAS  Google Scholar 

  12. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients.Transplantation 1995; 60: 225–232.

    Article  PubMed  CAS  Google Scholar 

  13. Vincenti F, Kirkman R, Light Set al. Interleukin-2 receptor blockade with dacluzimab to prevent acute rejection in renal transplantation.N Engl J Med 1998; 338: 161–165.

    Article  PubMed  CAS  Google Scholar 

  14. DeMattos AM, Norman DJ. OKT3 for treatment of rejection in renal transplantation.Clin Transplant 1993; 7: 374–381.

    Google Scholar 

  15. Morrisey PE, Gohh R, Shaffer Det al. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by Banff criteria.Transplantation 1997; 63: 845–848.

    Article  Google Scholar 

  16. Rubin RH. Infectious disease complications of renal transplantation.Kid Int 1993; 44: 221–230.

    Article  CAS  Google Scholar 

  17. Patel R, Snydman DR, Rubin RHet al. Cytomegalovirus prophylaxis in solid organ transplant recipients.Transplantation 1996; 61: 1279–1289.

    Article  PubMed  CAS  Google Scholar 

  18. Vosnides GG. Hepatitis C in renal transplantation.Kid Int 1997; 52: 843–861.

    Article  CAS  Google Scholar 

  19. Rostaing L, Demur C, Huyn A, Durand D, Lloveras JJ, Suc JM. Erythrocytosis after renal transplant study of erythroid progenitors and response to enalapril.Transplant Proc. 1994; 26: 280–281.

    PubMed  CAS  Google Scholar 

  20. Camerson JS. Recurrent primary disease andde novo nephritis following renal transplantation.pediatr Nephrol 1991; 5: 412–421.

    Article  Google Scholar 

  21. Mowry J, Ettenger RB, Ho WG, Cohen AH, Marik JL, Fine RN. Treatment of recurrent focal segmental glomerulosclerosis with high-dose cyclosporine A and plasmaphresis.Treatment Proc. 1993; 25: 1345–1346.

    CAS  Google Scholar 

  22. Menster M, Breen TJ, Sullivan EK, Fine RN. Growth-hormone treatment of renal transplant recipients: The National Co-operative Growth Study Experience-A report of the National Co-operative Growth Study and the North American Pediatric Renal Transplant Co-operative Study.J Pediatr 1997; 131: S20–24.

    Article  Google Scholar 

  23. Velosa JA. Strategies to prolong long-term renal allograft function.Transplantation Reviews 1998; 12: 1–13.

    Article  Google Scholar 

  24. Boubinder S, Hiesse C, Goupy C, Kriaa F, Marchand S, Carpenter B. Incidence and consequences of post-transplant lymphoproliferative disorders.J Nephrol 1997; 10: 136–145.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, NT #4310, 90048, Los Angeles, USA

    Asha Moudgil MD (Assistant Prof. of Pediatrics) & Stanley C. Jordan

Authors
  1. Asha Moudgil MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stanley C. Jordan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Asha Moudgil MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moudgil, A., Jordan, S.C. Renal transplantation in infants and children. Indian J Pediatr 66, 263–275 (1999). https://doi.org/10.1007/BF02761217

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02761217

Key words

Search

Navigation